Komori
Other Disclosures206APRISM BioLab Co.,LTDPharmaceuticals

Notice regarding the audio broadcast of the “Radio NIKKEI Japan Tour”

Audio distribution has begun for a recording of the Company’s presentation at the IR event held on 13 June 2026.

Worth reading
44Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Announced details

Audio archive of the “Radio NIKKEI Japan Tour: Bio IR & Hideaki Sakurai Stock Investment Seminar in Osaka”
Applicable field (uses covered by this announcement)

IR and information provision to investors

Launch date22 June 2026 (audio distribution available)
Relationship between the counterparty and the company
PRISM BioLab Co.,LTD206A
Relationship with the Company

The Company’s representative director spoke at the event, and the organiser is distributing a recording of the presentation as audio content.

CounterpartyRadio NIKKEI

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Source (materials cited by the company)

Radio NIKKEI audio distribution page (https://www.radionikkei.jp/japantour/260613osaka.html)

Announced details
ItemDetails
Names of Products / Services CoveredAudio archive of the “Radio NIKKEI Japan Tour: Bio IR & Hideaki Sakurai Stock Investment Seminar in Osaka”
CounterpartyRadio NIKKEI
Relationship with the CompanyThe Company’s representative director spoke at the event, and the organiser is distributing a recording of the presentation as audio content.
Launch date22 June 2026 (audio distribution available)
Applicable areaIR and information provision to investors
SourceRadio NIKKEI audio distribution page (https://www.radionikkei.jp/japantour/260613osaka.html)
Items this document does not state (12)
Counterparty overviewContract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocationLocation scaleQuantitative EffectsUsage historyImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To promote dialogue with shareholders and investors and deepen their understanding of the Company.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice regarding the audio broadcast of the “Radio NIKKEI Japan Tour” | PRISM BioLab Co.,LTD (206A) timely disclosure | Komori